The Shared Resources at UPCI include state-of-the-art facilities that provide infrastructure, technology, support, and expertise to enhance basic, translational, and clinical cancer research with a goal to provide outstanding service at reasonable cost. In addition to standard service offerings, most facilities will work with researchers to provide customized procedures as needed. Shared Resource Directors provide expert consultation and, in some cases, may participate as co-investigators on research faculty grants.
| Carolyn Anderson, PhD | Co-Director, In Vivo Imaging Facility (IVIF); Leader, Preclinical PET/CT Modality |
| Jan Hendrik Beumer, PharmD, PhD | Co-Director, Cancer Pharmacokinetics and Pharmacodynamics Facility (CPPF) |
| Uma Chandran, PhD | Director, Cancer Bioinformatics Services (CBS) |
| Rajiv Dhir, MD | Director, Tissue and Research Pathology Services (TARPS) |
| T. Kevin Hitchens, PhD, MBA | Leader, Preclinical MRI Modality (IVIF) |
| Frank Jenkins, PhD | Director, Biobehavioral Oncology Facility |
| Anna Lokshin, PhD | Director, Luminex Core Facility |
| Brian Miller, PharmD | Director, Investigational Drug Services (IDS) |
| James Mountz, MD, PhD | Co-Director, In Vivo Imaging Facility (IVIF); Leader, Clinical PET/CT and MRI Modalities |
| Joseph T. Newsome, DVM, DACLAM | Director, Animal Facility (AF) |
| Daniel P. Normolle, PhD | Director, Biostatistics Facility (BF) |
| John Schmitz, PhD | Co-Director, Cancer Pharmacokinetics and Pharmacodynamics Facility (CPPF) |
| Mark Schurdak, PhD | Director, Chemical Biology Facility (ChBF) |
| Simon Watkins, PhD | Director, Cell and Tissue Imaging Facility (CTIF) |
| Nathan Yates, PhD | Director, Cancer Proteomics Facility (CPF); Scientific Director, Biomedical Mass Spectrometry Center |
| Open | Director, Immunologic Monitoring and Cellular Products Laboratory (IMCPL) |
| Open | Director, Cytometry Facility (CF) |
| Open | Director, Cancer Genomics Facility (CGF) |
